分子酶学和药物靶点

  • 期刊 h 指数: 5
  • 期刊引用分数: 0.57
  • 期刊影响因子: 0.58
索引于
  • 中国知网(CNKI)
  • 普布隆斯
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

In osteoporotic ovariectomized rats, bone-targeting PLGA-derived lipid treatment delivery system decreases bone loss

Shashi Singh

The distribution of anti-osteoporotic medications at the right dose has proven difficult due to the lack of safety, efficacy, and specificity. In our research, bone-specific polyaspartic acid Asp) 8-DNPs were added to cathepsin K inhibitor loaded poly derived lipid hybrid nanoparticles to cure osteoporosis. DNPs shown their affinity for binding to hydroxyapatite and were successful in releasing cathepsin K inhibitors over the course of up to 5 days. The tartrate-resistant acid phosphatase activity and resorption-related genes in osteoclasts were drastically reduced by cathepsin K inhibitor loaded Asp 8-DNPs. The tibia and femur of animals showed high levels of Asp 8-DNP accumulation, as well as increased trabecular bone mass and more organised three-dimensional architecture in osteoporotic rat models. Herein, the bone targeted drug delivery system show its potential in treatment of osteoporosis

Keywords

Bone-targeting; Polyaspartic acid peptides; Drug delivery system; Osteoporosis; Anti-osteoporosis drug